Advocacy Actions
Online-Event: Healthy China 2030 by the German Health Alliance and the German Chamber of Commerce
The Heathcare Equipment (HCE) Working Group participated in the event "Healthy China 2020", co-organised by the German Health Alliance (GHA) and the German Chamber of Commerce (DIHK).
Read moreMeeting with the Centre for Drug and Medical Device Procurement of Sichuan Province on the new Provincial Procurement Platform
The Healthcare Equipment (HCE) Working Group hold a meeting with the Centre for Drug and Medical Device Procurement of Sichuan Province on the new provincial platform for procurement of disposable medical devices.
Read moreClosed-door workshop on the Chinese standardisation system and its impact on European businesses
On 22nd June, The European Delegation in China (EUD), the European Union Chamber of Commerce in China and the Seconded European Standardization Expert for China (SESEC) co-organised a workshop on Chinese Standardisation System and its Impact on European Businesses.
Read moreComments to the NMPA on the Provisions on Medical Device Registration Inhouse Inspection (Call for Comments)
On 21 June, the medical devices sector sent comments to the National Medical Products Administration on the the Provisions on Medical Device Registration Inhouse Inspection (Call for Comments).
Read moreBriefing Letter to the EU Delegation on the Administrative Measures for Medical Devices
Briefing Letter to the EU Delegation on the Administrative Measures for Medical Devices
Read moreComments to NMPA's Public Consultation on the Classification Rules for In Vitro Diagnostics
The medical devices sector sent comments to the National Medical Products Administration's public consultation on the Classification Rules for In Vitro Diagnostics.
Read moreComments to NMPA's Public Consultation on the In-Vitro Diagnostic Reagent Registration Application Data Requirements and Approval Document Format
The medical devices sector sent comments to the National Medical Products Administration's (NMPA) public consultation on the In-Vitro Diagnostic Reagent Registration Application Data Requirements and Approval Document Format.
Read moreComments to NMPA's Pulic Consultation on the Medical Device Registration Application Data Requirements and Approval Document Format
The medical devices sector sent comments to the National Medical Products Administration's (NMPA) public consultation on the Medical Device Registration Application Data Requirements and Approval Document Format.
Read moreComments to NMPA's Public Consultation on the Category of Medical Devices Exempeted from Clinical Evalutaion
The medical devices sector sent comments to the National Medical Products Administration's (NMPA) public consultation on the Category of Medical Devices Exempeted from Clinical Evalutaion.
Read moreComments to NMPA's Public Consultation on the Technical Guideline for Methodological Comparison Of In Vitro Diagnostic Reagents Free of Clinical Trials
The medical devices sent comments to the National Medical Products Administration's (NMPA) public consultation Technical Guideline for Methodological Comparison Of In Vitro Diagnostic Reagents Free of Clinical Trials.
Read more